Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2008
12/24/2008EP2004650A2 Process for the preparation of zaleplon and an intermediate thereof
12/24/2008EP2004647A1 Hiv inhibiting 3,4-dihydro-imidazoý4,5-b¨pyridin-5-ones
12/24/2008EP2004646A2 Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
12/24/2008EP2004645A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
12/24/2008EP2004644A1 Process for the preparation of tadalafil
12/24/2008EP2004643A1 Organic compounds
12/24/2008EP2004642A1 Bifunctional polyazamacrocyclic chelating agents
12/24/2008EP2004631A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
12/24/2008EP2004625A2 C-met protein kinase inhibitors for the treatment of proliferative disorders
12/24/2008EP2004624A1 Novel bi-aryl amines
12/24/2008EP1551804B1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
12/24/2008EP1545502A4 Keto cannabinoids with therapeutic indications
12/24/2008EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route
12/24/2008EP1147115B3 Tricyclic benzodiazepines as vasopressin receptor antagonists
12/24/2008EP1017399B1 Camptothecin analogs and methods of preparation thereof
12/24/2008DE102007028515A1 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 6- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives
12/24/2008CN101331132A [ (1H- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders
12/24/2008CN101331131A Pyrrolo [2, 3-b] pyridine derivatives as h3 receptor modulators
12/24/2008CN101331130A Tetrahydroquinolines, synthesis thereof, and intermediates thereto
12/24/2008CN101331129A Dibenzonaphthyridine derivatives and methods of use thereof
12/24/2008CN101330918A Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths
12/24/2008CN101328175A Yageine derivates having antineoplastic activity
12/24/2008CN101328174A Method for preparing 3-(2-chloroethyl)-2-methyl-4H- naphthyridine[1,2-a]pyrimidine-4-ketone
12/24/2008CN101328173A Method for preparing 6-fluoro-3-(4- piperidyl)-1,2-benzo isoxazole hydrochlorate
12/24/2008CN101328172A 4-substituted 2,7-phthalazine compound, and preparation and usethereof
12/24/2008CN100445283C Process for preparing photoresponsive azobenaene-perylene
12/24/2008CN100445282C Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
12/24/2008CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2691237A1 Compounds and uses thereof-848
12/24/2008CA2691227A1 Activators and therapeutic applications thereof
12/24/2008CA2691223A1 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and aids
12/24/2008CA2691150A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/24/2008CA2690410A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008CA2689208A1 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
12/24/2008CA2687909A1 Indolin-2-ones and aza-indolin-2-ones
12/24/2008CA2687255A1 Heteroarylamide pyrimidone derivatives
12/23/2008US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors
12/23/2008US7468376 Pyrazolopyridine derivates
12/23/2008US7468375 Inhibitors of the HIV integrase enzyme
12/23/2008US7468370 [1,7]naphthyridines as PDE4 inhibitors
12/23/2008US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns
12/23/2008CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway
12/18/2008WO2008153793A2 Gamma secretase modulators
12/18/2008WO2008153027A1 Pyrroloquinoline derivative and use thereof
12/18/2008WO2008152603A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/18/2008WO2008152462A1 A process of sulfoxidation of biologically active compounds
12/18/2008WO2008152068A2 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008152013A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008WO2008151927A2 6-n-substituted benz imidazole derivatives as acid pump antagonists
12/18/2008WO2008151558A1 Azaindole-indole coupled derivatives, preparation methods and uses thereof
12/18/2008WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases
12/18/2008WO2008112695A3 Pyrazolo [3,4-d] pyrimidines and 1, 2, 5, 6-tetraaza- as- indacenes as protein kinase inhibitors for cancer treatment
12/18/2008WO2008089201A3 Heterocyclic-substituted piperidine as orl-1 ligands
12/18/2008WO2008080056A3 Pyridazinones and furan-containing compounds
12/18/2008WO2008043072A3 Cd80 antagonists for treating neoplastic disorders
12/18/2008WO2007092436A3 Compounds for treating inflammatory disorders, demyelinating disorders and cancers
12/18/2008US20080312444 Process for Preparing Bicyclic Compounds
12/18/2008US20080312434 Process for imidazo [4,5-c] pyridin-4-amines
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312272 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
12/18/2008US20080312271 Azabenzimidazolyl compounds
12/18/2008US20080312270 Compounds and methods useful for treating asthma and allergic inflammation
12/18/2008US20080312269 Therapeutic Agents
12/18/2008US20080312242 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
12/18/2008US20080312240 Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312233 Therapeutic Morpholino-Substituted Compounds
12/18/2008US20080312230 Organic Compounds
12/18/2008US20080312229 Organic Compounds
12/18/2008US20080312227 Substituted Pyrido(2,3-D) Pyrimidine Derivatives Useful as Medicines for the Treatment of Autoimmune Disorders
12/18/2008US20080312211 Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154
12/18/2008US20080311636 Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid
12/18/2008US20080311208 Pharmaceutical Formulations Useful in the Treatment of Insomnia
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2692922A1 Azaindole-indole coupled derivatives, preparation methods and uses thereof
12/18/2008CA2690569A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008CA2690567A1 New compounds
12/18/2008CA2690455A1 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
12/18/2008CA2689948A1 Gamma secretase modulators
12/18/2008CA2689102A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/17/2008EP2003132A1 Hetero compound
12/17/2008EP2002863A1 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2002836A1 Cyclocondensed azaindoles active as kinase inhibitors
12/17/2008EP2002835A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
12/17/2008EP2001880A2 Heterobicyclic pyrazole compounds and methods of use
12/17/2008EP2001879A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
12/17/2008EP2001878A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
12/17/2008EP2001868A1 Inhibitors of the interaction between mdm2 and p53
12/17/2008EP2001863A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
12/17/2008EP2001850A1 Process for preparing 6,7-dihydro-5h-imidazoý1,5-a¨pyridin-8-one
12/17/2008EP1809607B1 Sulfonyl benzimidazole derivatives
12/17/2008EP1802620B1 Method for enantioselective preparation of sulphoxide derivatives
12/17/2008EP1385504B1 Method of inhibiting adhesion formation
12/17/2008CN101326187A Pyrrolo[2,3-c]pyridine derivatives
12/17/2008CN101326186A Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
12/17/2008CN101326185A Aryl acetic acid and ester derivatives and their uses as antiinflammatory
12/17/2008CN101326184A Bis-heterocyclic imidazolyl compounds
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 646